K36E/R37E (University of California Davis)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameK36E/R37E (University of California Davis)
Drug Alias Namefractalkine-CD dominant negative mutants (University of California Davis)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionIntegrin stimulantsC-X3-C motif chemokine receptor 1 antagonists
TargetsIntegrinC-X3-C motif chemokine receptor 1
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of California Davis
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A